Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Stock Quote Today & Recent News Kane Biotech Inc V.KNE

Alternate Symbol(s):  KNBIF

Healthcare Biotechnology
Kane Biotech Inc. is a Canada-based biotechnology company engaged in the research, development and commercialization of technologies and products that prevent and remove microbial biofilms. The Company has a portfolio of biotechnologies, intellectual property (66 patents and patents pending, trade secrets and trademarks) and products developed by its own biofilm research expertise and acquired... see more
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >

Current News (TSXV:KNE)

Kane Biotech Announces $3,000,000 Private Placement Offering

GlobeNewswire December 3, 2024

Kane Biotech Announces Third Quarter 2024 Financial Results

GlobeNewswire November 28, 2024

Kane Biotech Announces Change in US Distribution Partner for revyve(TM) Antimicrobial Wound Gel

GlobeNewswire November 27, 2024

Kane Biotech to Release Third Quarter 2024 Financial Results on November 28, 2024

GlobeNewswire November 21, 2024

Kane Biotech Announces Health Canada Approval of revyve(TM) Antimicrobial Wound Gel

GlobeNewswire November 14, 2024

Kane Biotech Provides Investor Update Following FB Dermatology Acquisition Announcement

GlobeNewswire November 14, 2024

Canadian Investment Regulatory Organization Trade Resumption - KNE

Canada NewsWire November 12, 2024

Kane Biotech Announces Agreement to Acquire FB Dermatology

GlobeNewswire November 12, 2024

Canadian Investment Regulatory Organization Trading Halt - KNE

Canada NewsWire November 12, 2024
View More News ››

Opinion & Analysis (TSXV:KNE)

Emerging opportunity in a growing, high-value dermatological market

Ryan Dhillon April 11, 2024

Big Copper Fox Metals’ (V.CUU) shareholders under water?

Stockhouse Editorial September 17, 2014

John Kaiser: ‘The bull is back,’ Stockhouse poster says

Stockhouse Editorial February 5, 2014
View More Opinion ››

Bullboard Posts (TSXV:KNE)

RE:RE:Somebody wants to get in...

Yup, I've noticed :(
francoisl13 - 8 days ago

RE:RE:Somebody wants to get in...

It's always a waste of time following market trades and volumes. Research Capital analysts only follow companies that they sign up...
KevinOleary - 9 days ago

RE:Somebody wants to get in...

yup and right after somebody wanted out, big dump down to .09. 
RoyMax123 - 9 days ago

Somebody wants to get in...

Good volume from Research Capital Corp. today at $0.105 which is above the private placement offer info released by KNE a few weeks ago...
francoisl13 - 9 days ago

Aurena lab video

Cool video from Aurena Lab showing the Revyve wound gel spray production line.. LinkedIN link to Aurena video GLTA!
francoisl13 - December 2, 2024

RE:RE:RE:RE:New Press Release - Kane Biotech Announces Third Quarter 2024 Financial Results

Marc said Omni won't be a big market. It's actually KNE's dispersin product, private labelled as Omni so you won't see...
KevinOleary - November 29, 2024
View more Bullboard ››

Forge Resources Corp.

Forge Resources Corp.

Forge Resources Corp. is a junior exploration company. The Company is engaged in the business of the exploration and ...
View More »